Op-Ed: State bills will ensure patients access to safe, advanced drugs

Published June 24, 2013 4:00am ET



Biological drugs are modern medical miracles. Derived from living organisms, this complex class of drugs — known as “biologics” — has proven astonishingly effective in treating a wide range of diseases, including rheumatoid arthritis, cancer, and a host of complex autoimmune disorders.

Thanks to the 2010 Patient Protection and Affordable Care Act, patients will soon have access to more affordable versions of these medicines. That legislation empowered the Food and Drug Administration to begin approving “biosimilars.”

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.